© 2025 Replicate Bioscience | All rights reserved.

Investors & Partners

MAKINg srRNA TREATMENTS POSSIBLE

Founded in 1999, ATP is a leader in life sciences venture capital, with $2.65 billion in committed capital and offices in New York, London, San Francisco, and Cambridge, MA. ATP creates companies starting at various stages, from pre-IP ideas to asset spinouts, investing in them from seed stage through IPO and beyond. The core of ATP’s strategy is to provide flexible capital and access to a world-class team of venture partners and EIRs, to build sustainable, research-driven enterprises that improve human lives. For more information, visit www.appletreepartners.com.

Apple Tree Partners logo.
Apple Tree Partners logo.
Partner with us
We’re a collaborative group always seeking new ways of thinking and growing. Get in contact below for information about partnering.
START THE CONVERSATIOn
A segment of yellow, single-stranded RNA arcs across the bottom left of the screen. Behind it is a blue background overlaid with rows of simple human silhouettes. A bright white light trail animates following the arch of the RNA. A segment of yellow, single-stranded RNA arcs across the bottom left of the screen. Behind it is a blue background overlaid with rows of simple human silhouettes. A bright white light trail animates following the arch of the RNA.